Electronic unified therapy record as a clinical risk management tool in the Italian healthcare system.
digitalization
drug chart
electronic medical record
medication error
therapy
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
13
04
2022
accepted:
18
07
2022
entrez:
22
8
2022
pubmed:
23
8
2022
medline:
24
8
2022
Statut:
epublish
Résumé
Digitization of health records is still struggling to take hold in the Italian healthcare context, where medical records are still largely kept manually on paper. Besides being anachronistic, this practice is particularly critical if applied to the drug chart. Poor handwriting and transcription errors can generate medication errors and thus represent a potential source of adverse events. In the present study, we attempt to test the hypothesis that the application of a computerized medical record model may represent a useful tool for managing clinical risk and medical expenditure. We shall do so through the analysis of the preliminary results of the application of such a model in two private hospitals in Northern Italy. The results, although preliminary, are encouraging. Among the benefits of digitizing drug records, we recorded a greater accuracy and adequacy of prescriptions, a reduction in the overall workload for nurses (no longer required to manually transcribe the list of drugs from one chart to another), as well as an optimization of the management of drug stocks by hospital pharmacies. The results in terms of clinical risk reduction will be monitored through a prospective cohort study that will take place in the coming months.
Identifiants
pubmed: 35991051
doi: 10.3389/fpubh.2022.919543
pmc: PMC9381968
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
919543Informations de copyright
Copyright © 2022 Pesel, Ricci, Gibelli and Sirignano.
Déclaration de conflit d'intérêts
Author GP was employed by Policlinico Triestino SPA. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Medinfo. 1995;8 Pt 1:295
pubmed: 8591176
Qual Saf Health Care. 2005 Aug;14(4):279-83
pubmed: 16076793
BMJ Qual Saf. 2020 Oct;29(10):1-2
pubmed: 32371457
J Am Med Inform Assoc. 2013 May 1;20(3):470-6
pubmed: 23425440
Syst Rev. 2014 Jun 04;3:56
pubmed: 24894078
Pediatrics. 2009 Apr;123(4):1184-90
pubmed: 19336379
J Am Med Inform Assoc. 2004 Mar-Apr;11(2):100-3
pubmed: 14633934
J Am Med Inform Assoc. 1998 May-Jun;5(3):305-14
pubmed: 9609500
BMC Health Serv Res. 2019 Sep 6;19(1):644
pubmed: 31492182
Am J Med. 2013 Oct;126(10):853-7
pubmed: 24054954
BMJ. 2007 Jan 13;334(7584):51
pubmed: 17218667
JAMA. 1998 Oct 21;280(15):1311-6
pubmed: 9794308
Am Health Drug Benefits. 2012 Nov;5(7):1-10
pubmed: 24991335
Br J Clin Pharmacol. 2009 Jun;67(6):624-8
pubmed: 19594530
J Community Hosp Intern Med Perspect. 2016 Sep 07;6(4):31758
pubmed: 27609720
Methods Inf Med. 2004;43(5):537-42
pubmed: 15702216
J Am Med Inform Assoc. 2017 Mar 01;24(2):413-422
pubmed: 28395016
J Am Med Inform Assoc. 2008 Sep-Oct;15(5):585-600
pubmed: 18579832